- Home
- AACT vs DNA Comparison
AACT vs DNA Comparison
Compare AACT & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AACT
- DNA
- Stock Information
- Founded
- AACT 2021
- DNA 2008
- Country
- AACT United States
- DNA United States
- Employees
- AACT N/A
- DNA N/A
- Industry
- AACT
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AACT
- DNA Health Care
- Exchange
- AACT Nasdaq
- DNA Nasdaq
- Market Cap
- AACT 690.3M
- DNA 562.1M
- IPO Year
- AACT 2023
- DNA N/A
- Fundamental
- Price
- AACT $11.06
- DNA $10.82
- Analyst Decision
- AACT
- DNA Hold
- Analyst Count
- AACT 0
- DNA 6
- Target Price
- AACT N/A
- DNA $37.80
- AVG Volume (30 Days)
- AACT 152.1K
- DNA 1.8M
- Earning Date
- AACT 01-01-0001
- DNA 02-25-2025
- Dividend Yield
- AACT N/A
- DNA N/A
- EPS Growth
- AACT 48.19
- DNA N/A
- EPS
- AACT 0.43
- DNA N/A
- Revenue
- AACT N/A
- DNA $217,951,000.00
- Revenue This Year
- AACT N/A
- DNA N/A
- Revenue Next Year
- AACT N/A
- DNA N/A
- P/E Ratio
- AACT $25.72
- DNA N/A
- Revenue Growth
- AACT N/A
- DNA N/A
- 52 Week Low
- AACT $10.48
- DNA $5.26
- 52 Week High
- AACT $11.07
- DNA $64.40
- Technical
- Relative Strength Index (RSI)
- AACT 74.01
- DNA 43.22
- Support Level
- AACT $11.04
- DNA $11.21
- Resistance Level
- AACT $11.07
- DNA $15.96
- Average True Range (ATR)
- AACT 0.02
- DNA 1.85
- MACD
- AACT 0.00
- DNA -0.40
- Stochastic Oscillator
- AACT 85.72
- DNA 0.08
About AACT Ares Acquisition Corporation II
Ares Acquisition Corp II is a blank check company.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.